Olga Antipova

6PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 12, 2026
How Intelligent Is xCELLigence? Classification of Doxorubicin Cytotoxicity Based on Kinetic Profiling.

|Apr 03, 2026
[Research of interaction of fluorescent anti-CD133 DNA aptamers with glioblastoma cell cultures using flow cytometry].

V L Ivko, V E Makeeva, O M Antipova

|Sep 13, 2025
Real-Time Kinetics of Internalization of Anti-EGFR DNA Aptamers and Aptamer Constructs into Cells Derived from Glioblastoma Patients as Indicated by Doxorubicin.

Valeria Ivko, Olga Antipova, Boris Ivanov

|Feb 09, 2024
[Is it possible to detect surface antigen CD133 on patient-derived glioblastoma continuous cell cultures using fluorescent aptamers?]

V L Moiseenko, O M Antipova, S A Pavlova

|Feb 09, 2024
[Covalently conjugated DNA aptamer with doxorubicin as in vitro model for effective targeted drug delivery to human glioblastoma tumor cells].

Ya A Sliman, N S Samoylenkova, O M Antipova

|Dec 19, 2022
[Molecular markers of neuro-oncogenesis in patients with glioblastoma].

A M Kopylov, O A Antipova, G V Pavlova

Pageof 1

Frequent Collaborators

6 joint publications

Alexey Kopylov

6 joint publications

Galina Pavlova

4 joint publications

Valeria Ivko

3 joint publications

I N Pronin